Cargando…

Clinical and microbiological efficacy of continuous versus intermittent application of meropenem in critically ill patients: a randomized open-label controlled trial

INTRODUCTION: Meropenem bactericidal activity depends on the time when the free drug concentrations remain above the minimum inhibitory concentration of pathogens. The goal of this study was to compare clinical and bacteriological efficacy of continuous meropenem infusion versus bolus administration...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chytra, Ivan, Stepan, Martin, Benes, Jan, Pelnar, Petr, Zidkova, Alexandra, Bergerova, Tamara, Pradl, Richard, Kasal, Eduard
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2012
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3580671/ https://www.ncbi.nlm.nih.gov/pubmed/22742765 http://dx.doi.org/10.1186/cc11405

Ejemplares similares

Clinical and microbiological efficacy of continuous versus intermittent administration of vancomycin in critical care patients
por: Štepán, M, et al.
Publicado: (2009)

Esophageal Doppler-guided fluid management decreases blood lactate levels in multiple-trauma patients: a randomized controlled trial
por: Chytra, Ivan, et al.
Publicado: (2007)

Balanced study groups in a randomized trial - authors' response
por: Benes, Jan, et al.
Publicado: (2011)

Intraoperative fluid optimization using stroke volume variation in high risk surgical patients: results of prospective randomized study
por: Benes, Jan, et al.
Publicado: (2010)

Fluid management guided by a continuous non-invasive arterial pressure device is associated with decreased postoperative morbidity after total knee and hip replacement
por: Benes, Jan, et al.
Publicado: (2015)

Intraoperative fluid optimization using stroke volume variation in high-risk surgical patients: preliminary results of a randomized prospective single-center study
por: Beneš, J, et al.
Publicado: (2009)

Quality of life 1 year after intensive care
por: Zidková, A, et al.
Publicado: (2009)

The influence of empiric antimicrobial therapy on acquired pulmonary infection in patients with a chest injury on ICU
por: Chytra, I, et al.
Publicado: (2000)

Cost analysis of the stroke volume variation guided perioperative hemodynamic optimization – an economic evaluation of the SVVOPT trial results
por: Benes, Jan, et al.
Publicado: (2014)

Continuous infusion versus intermittent administration of meropenem in critically ill patients: a pilot study
por: Thalhammer, F, et al.
Publicado: (1999)

Cost-effectiveness analysis of stroke volume variation guided perioperative hemodynamic optimization
por: Benes, J, et al.
Publicado: (2013)

Meropenem administration by intermittent infusion versus continuous infusion for the treatment of nosocomial pneumonia
por: Lorente, L, et al.
Publicado: (2005)

402 Pharmacokinetics of Extended vs Intermittent Intravenous Infusion of Meropenem in Critically Ill Patients Receiving Continuous Veno-Venous Haemofiltration
por: Frippiat, Frédéric, et al.
Publicado: (2014)

Continuous infusion of meropenem in critically ill patients: practical considerations
por: Taccone, Fabio Silvio
Publicado: (2012)

Meropenem: continuous or extended infusion?
por: Frippiat, Frédéric, et al.
Publicado: (2020)

Clearance of meropenem during continuous renal replacement therapy in critically ill patients
por: Thalhammer, F, et al.
Publicado: (1999)

Pharmacokinetics of meropenem during continuous renal replacement therapy in critically ill patients
por: Solé Violan, J, et al.
Publicado: (2014)

Preliminary validation of new prognostic scoring system in patients with invasive meningococcal disease
por: Kasal, K, et al.
Publicado: (1999)

Impact of cumulative fluid balance on the pharmacokinetics of extended infusion meropenem in critically ill patients with sepsis
por: Pařízková, Renata Černá, et al.
Publicado: (2021)

Pharmacokinetics and Pharmacodynamics of Meropenem by Extended or Continuous Infusion in Low Body Weight Critically Ill Patients
por: Luque, Sonia, et al.
Publicado: (2021)

Relationship between Pharmacokinetic/Pharmacodynamic Target Attainment and Microbiological Outcome in Critically Ill COVID-19 Patients with Documented Gram-Negative Superinfections Treated with TDM-Guided Continuous-Infusion Meropenem
por: Sanz Codina, Maria, et al.
Publicado: (2022)

Microbiological Assessment of Titanium Plates Coated with PLGA, Chitosan, and/or Meropenem: An In Vitro Study
por: Al-Qubaisey, Mohammad, et al.
Publicado: (2022)

Optimal loading dose of meropenem before continuous infusion in critically ill patients: a simulation study
por: Liebchen, Uwe, et al.
Publicado: (2021)

Meropenem pharmacokinetics in critically ill patients with or without burn treated with or without continuous veno‐venous haemofiltration
por: Selig, Daniel J., et al.
Publicado: (2021)

Clinical outcomes of prolonged infusion (extended infusion or continuous infusion) versus intermittent bolus of meropenem in severe infection: A meta-analysis
por: Yu, Zhenwei, et al.
Publicado: (2018)

Pharmacokinetics of meropenem in critically ill patients in Saudi Arabia
por: Alsultan, Abdullah, et al.
Publicado: (2021)

Meropenem Pharmacokinetics and Target Attainment in Critically Ill Patients
por: Gan, Yuhong, et al.
Publicado: (2023)

Pharmacokinetic/Pharmacodynamic Target Attainment of Continuous Infusion Piperacillin–Tazobactam or Meropenem and Microbiological Outcome among Urologic Patients with Documented Gram-Negative Infections
por: Berrino, Pasquale Maria, et al.
Publicado: (2023)

Acute-on-chronic liver failure alters meropenem pharmacokinetics in critically ill patients with continuous hemodialysis: an observational study
por: Grensemann, Jörn, et al.
Publicado: (2020)

Pharmacokinetic and Pharmacodynamic Efficacies of Continuous versus Intermittent Administration of Meropenem in Patients with Severe Sepsis and Septic Shock: A Prospective Randomized Pilot Study
por: Zhao, Hui-Ying, et al.
Publicado: (2017)

Renal replacement therapy for critically ill patients: an intermittent continuity
por: Ricci, Zaccaria, et al.
Publicado: (2014)

Intrapulmonary concentrations of meropenem administered by continuous infusion in critically ill patients with nosocomial pneumonia: a randomized pharmacokinetic trial
por: Benítez-Cano, Adela, et al.
Publicado: (2020)

Comparison of the Effectiveness of Prolonged Infusion and Intermittent Infusion of Meropenem in Patients With Sepsis: A Meta-Analysis
por: Lokhandwala, Adnan, et al.
Publicado: (2023)

Cefepime in critically ill patients: continuous infusion versus intermittent regimen
por: Georges, B, et al.
Publicado: (2001)

Continuous Vancomycin Infusion versus Intermittent Infusion in Critically Ill Patients
por: Maluangnon, Chailat, et al.
Publicado: (2022)

The metabolic effects of intermittent versus continuous feeding in critically ill patients
por: Wilkinson, D., et al.
Publicado: (2023)

Population pharmacokinetics of standard-dose meropenem in critically ill patients on continuous renal replacement therapy: a prospective observational trial
por: Onichimowski, Dariusz, et al.
Publicado: (2020)

Meropenem clearance by continuous haemofiltration: a comparison of in vivo and in vitro data
por: Giles, LJ, et al.
Publicado: (1999)

Continuous Infusions of Meropenem in Ambulatory Care: Clinical Efficacy, Safety and Stability
por: Manning, Laurens, et al.
Publicado: (2014)

Extended Versus Intermittent Meropenem Infusion in the Treatment of Nosocomial Pneumonia: A Retrospective Single-Center Study
por: Hyun, Dong-gon, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_jrgc9ue7p8grdqdljl27g39rut